TRAF6 and graft versus host disease: In a mouse model, the overexpression of miR-146a was associated with reduced GvHD severity caused by the negative regulation of T-cells from donors by targeting TNF receptor-associated factor 6 (TRAF6), and subsequent TNF transcription inhibition [161].